Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing. Int. Med. Res. J. [Internet]. 2026 Sep. 9 [cited 2026 Oct. 23];11(1). Available from: https://journal.nih.gov.my/index.php/imrj/article/view/166